UK researchers find lateral flow devices identify infectious Covid-19
Researchers from the University of Oxford in the UK have found out that the rapid lateral flow tests could identify…
20 Jan 2021
Covid-19 variants: will the reliability of tests be affected?
Covid-19 variants represent a confusing factor in the spread of the pandemic. From the UK and Brazil to South Africa, the US and now Germany, mutant strains of Covid-19 have…
20 Jan 2021
Thermo Fisher to acquire Covid-19 test developer Mesa Biotech
Thermo Fisher Scientific has signed an agreement to acquire US-based Mesa Biotech, a molecular diagnostics company that developed rapid Covid-19 test kits, for $450m. Mesa Biotech developed a PCR-based rapid…
20 Jan 2021
NIH to enter Phase II of Covid-19 biomarker development contract
The National Institutes of Health (NIH) unit National Cancer Institute (NCI) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) are set to enter Phase II of a multi-phase…
18 Jan 2021
US scientists develop blood test for high-risk Covid-19 patients
Scientists at Washington University School of Medicine in St Louis, US, have developed a new simple and rapid test that can measure mitochondrial DNA in the blood of a Covid-19…
18 Jan 2021
Hologic kicks off 2021 with acquisitions in breast cancer market
Women’s health medtech specialist Hologic has hit the ground running in the new year, making two acquisitions in the first week of 2021. On 4 January, Hologic closed its acquisition…
15 Jan 2021
UK MHRA authorises integrated imaging technology for Covid-19
The UK Medicines & Healthcare products Regulatory Agency (MHRA) has approved the use of Perspectum’s magnetic resonance imaging (MRI)-based technology, CoverScan MD, for mapping the effects of Covid-19 on various…